0001209191-23-018261.txt : 20230313 0001209191-23-018261.hdr.sgml : 20230313 20230313183009 ACCESSION NUMBER: 0001209191-23-018261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Engelson Erik T. CENTRAL INDEX KEY: 0001839384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 23728637 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0001652724 Lucira Health, Inc. LHDX 0001839384 Engelson Erik T. C/O LUCIRA HEALTH INC. 1412 62ND ST EMERYVILLE CA 94608 1 1 0 0 President and Chief Executive Common Stock 2023-03-03 4 M 0 574666 0.82 A 657948 D Common Stock 2023-03-03 4 S 0 574666 1.03 D 83282 D Common Stock 2023-03-03 4 S 0 60000 1.09 D 23282 D Common Stock 46400 I See Footnotes Common Stock 191705 I See Footnotes Common Stock 0.82 2023-03-03 4 M 0 574666 0.00 D 2029-04-09 Common Stock 574666 0 D The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee. The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date. /s/ Erik Engelson 2023-03-13